Immunic
IMUX
IMUX
57 hedge funds and large institutions have $62.1M invested in Immunic in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less capital invested
Capital invested by funds: $75.7M → $62.1M (-$13.7M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
86% less call options, than puts
Call options by funds: $60K | Put options by funds: $419K
Holders
57
Holding in Top 10
1
Calls
$60K
Puts
$419K
Top Buyers
| 1 | +$384K | |
| 2 | +$368K | |
| 3 | +$321K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$130K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$90.9K |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$556K | |
| 3 | -$506K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$316K |
| 5 |
Two Sigma Advisers
New York
|
-$139K |